RSV prophylaxis for high-risk infants is achieved with which monoclonal antibody?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the Pediatric Respiratory Exam with our comprehensive study materials. Engage with flashcards and multiple-choice questions. Each question comes with hints and explanations. Get exam-ready with confidence!

Multiple Choice

RSV prophylaxis for high-risk infants is achieved with which monoclonal antibody?

Explanation:
RSV prophylaxis in high‑risk infants is achieved with a monoclonal antibody that provides passive protection by directly neutralizing RSV. This antibody targets the virus’s fusion (F) protein, blocking entry into cells and reducing the risk of hospitalization from RSV bronchiolitis. It is given as monthly injections during the RSV season to infants who are most at risk, such as those who are very preterm or have certain heart or lung conditions. The other monoclonal antibodies listed are used for different diseases (for example, targeting CD20, HER2, or VEGF) and are not used for RSV prevention.

RSV prophylaxis in high‑risk infants is achieved with a monoclonal antibody that provides passive protection by directly neutralizing RSV. This antibody targets the virus’s fusion (F) protein, blocking entry into cells and reducing the risk of hospitalization from RSV bronchiolitis. It is given as monthly injections during the RSV season to infants who are most at risk, such as those who are very preterm or have certain heart or lung conditions. The other monoclonal antibodies listed are used for different diseases (for example, targeting CD20, HER2, or VEGF) and are not used for RSV prevention.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy